Phase II Study of Bicalutamide and Dutasteride for Prostate Cytoreduction Prior to Permanent Implant I-125 Prostate Brachytherapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Bicalutamide (Primary) ; Dutasteride; LHRH receptor agonists; Tamoxifen
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 08 May 2013 Planned end date changed from 1 Mar 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.